Literature DB >> 10371227

Profile for estimating risk of heart failure.

W B Kannel1, R B D'Agostino, H Silbershatz, A J Belanger, P W Wilson, D Levy.   

Abstract

CONTEXT: We devised a risk appraisal function to assess the hazard of heart failure in persons who are predisposed by coronary disease, hypertension, or valvular heart disease.
OBJECTIVE: To provide general practitioners and internists with a cost-effective method to select people at high risk who are likely to have impaired left ventricular systolic function and may therefore require further evaluation and aggressive preventive measures.
METHODS: The routinely measured risk factors used in constructing the heart failure profile include age, electrocardiographic left ventricular hypertrophy, cardiomegaly on chest x-ray film, heart rate, systolic blood pressure, vital capacity, diabetes mellitus, evidence of myocardial infarction, and valvular disease or hypertension. Based on 486 heart failure cases during 38 years of follow-up, 4-year probabilities of failure were computed using the pooled logistic regression model for each sex; a simple point score system was employed. A multivariate profile was also produced without the vital capacity or chest x-ray film because these may not be readily available in some clinical settings.
RESULTS: Using the risk factors that make up the multivariate risk formulation-derived from ordinary office procedures-the probability of developing heart failure can be estimated and compared with the average risk for persons of the same age and sex. Using this risk profile, 60% of events in men and 73% in women occurred in subjects in the top quintile of multivariate risk.
CONCLUSIONS: Using this multivariate risk formulation, it is possible to identify high-risk candidates for heart failure who are likely to have a substantial yield of positive findings when tested for objective evidence of presymptomatic left ventricular dysfunction. The risk profile may also identify candidates who are at high risk for heart failure because of multiple, marginal risk factor abnormalities that might otherwise be overlooked.

Entities:  

Mesh:

Year:  1999        PMID: 10371227     DOI: 10.1001/archinte.159.11.1197

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  117 in total

1.  Review of recent Framingham study hypertension research.

Authors:  W B Kannel
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

3.  Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study.

Authors:  Javed Butler; Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Samer S Najjar; Kim C Sutton-Tyrrell; Tamara B Harris; Stephen B Kritchevsky; Donald M Lloyd-Jones; Anne B Newman; Bruce M Psaty
Journal:  Heart       Date:  2011-06-02       Impact factor: 5.994

Review 4.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

5.  Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

Authors:  J Gustav Smith; Christopher Newton-Cheh; Peter Almgren; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Thomas J Wang; Olle Melander
Journal:  J Am Coll Cardiol       Date:  2010-11-16       Impact factor: 24.094

6.  The epidemiology of congestive heart failure: the Framingham Heart Study perspective.

Authors:  Syed S Mahmood; Thomas J Wang
Journal:  Glob Heart       Date:  2013-03-01

7.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

Review 8.  A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification.

Authors:  Faisal M Merchant; Hui Zheng; Thomas Bigger; Richard Steinman; Takanori Ikeda; Roberto F E Pedretti; Jorge A Salerno-Uriarte; Catherine Klersy; Paul S Chan; Cheryl Bartone; Stefan H Hohnloser; Jeremy N Ruskin; Antonis A Armoundas
Journal:  Am Heart J       Date:  2013-09-18       Impact factor: 4.749

9.  Therapies for Preventing Heart Failure.

Authors:  Richard F. Wright
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

10.  Incident heart failure prediction in the elderly: the health ABC heart failure score.

Authors:  Javed Butler; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Rhonda Belue; Nicolas Rodondi; Melissa Garcia; Douglas C Bauer; Suzanne Satterfield; Andrew L Smith; Viola Vaccarino; Anne B Newman; Tamara B Harris; Peter W F Wilson; Stephen B Kritchevsky
Journal:  Circ Heart Fail       Date:  2008-07       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.